Document is current
Any future updates will be listed below
-
Authors
Manjunatha, Ujjini H. https://orcid.org/0000-0002-7461-9303
Lakshminarayana, Suresh B. https://orcid.org/0000-0002-9133-3147
Jumani, Rajiv S.
Chao, Alexander T.
Young, Joseph M.
Gable, Jonathan E.
Knapp, Mark
Hanna, Imad
Galarneau, Jean-Rene
Cantwell, John
Kulkarni, Upendra
Turner, Michael
Lu, Peichao
Darrell, Kristen H.
Watson, Lucy C. https://orcid.org/0009-0000-1907-768X
Chan, Katherine
Patra, Debjani https://orcid.org/0000-0003-4343-4645
Mamo, Mulugeta
Luu, Catherine
Cuellar, Carlos
Shaul, Jacob
Xiao, Linda
Chen, Ying-Bo
Carney, Shannon K.
Lakshman, Jay
Osborne, Colin S.
Zambriski, Jennifer A.
Aziz, Natasha https://orcid.org/0000-0001-8195-1446
Sarko, Christopher
Diagana, Thierry T. https://orcid.org/0000-0002-8520-5683
-
Funding
Funding for this research was provided by:
Wellcome Trust (219639/Z/19/Z, 219639/Z/19/Z)
Bill and Melinda Gates Foundation (OPP1117400, OPP1117400, OPP1117400)
Novartis
- License Information
-
More Information
Article History
Received: 17 January 2024
Accepted: 15 August 2024
First Online: 8 October 2024
Competing interests
: Multiple authors (U.H.M., S.B.L., R.S.J., A.T.C., J.M.Y., J.E.G., M.K., I.H., J.-R.G., J.C., U.K., M.T., P.L., K.H.D., K.C., D.P., M.M., C.L., C.C., J.S., L.X., Y.-B.C., J.L., C.S.O., N.A., C.S. and T.T.D.) are employees of Novartis and some of them have shares in the company. Compounds described in this report have been patented by Novartis, with J.M.Y., M.T. and P.L. listed as authors (US Patent WO/2022/079616). The other authors declare no competing interests.
